Asthma: Eosinophil Disease, Mast Cell Disease, or Both?

Por Bradding, Peter
Publicado em 2008

The K(+) channels K(Ca)3.1 and K(v)1.3 as novel targets for asthma therapy

Por Bradding, Peter, Wulff, Heike
Publicado em 2009

Mast cells in airway diseases and interstitial lung disease

Por Cruse, Glenn, Bradding, Peter
Publicado no Eur J Pharmacol (2015)

Ca(2+) signalling in fibroblasts and the therapeutic potential of K(Ca)3.1 channel blockers in fibrotic diseases

Por Roach, Katy M., Bradding, Peter
Publicado no Br J Pharmacol (2020)

IgE alone promotes human lung mast cell survival through the autocrine production of IL-6

Por Cruse, Glenn, Cockerill, Sarah, Bradding, Peter
Publicado em 2008

Multigene family isoform profiling from blood cell lineages

Por Bradding Peter, Conley Edward C, Dewson Grant
Publicado em 2002-08-01

Multigene family isoform profiling from blood cell lineages

Por Dewson, Grant, Conley, Edward C, Bradding, Peter
Publicado em 2002

Pro: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment

Por Murphy, Anna C., Boddy, Claire, Bradding, Peter
Publicado no Breathe (Sheff) (2021)

Asthma exacerbations: prevention is better than cure

Por Shaw, Dominick E, Green, Ruth H, Bradding, Peter
Publicado em 2005

A novel FcεRIβ-chain truncation regulates human mast cell proliferation and survival

Por Cruse, Glenn, Kaur, Davinder, Leyland, Mark, Bradding, Peter
Publicado em 2010

CADM1 isoforms differentially regulate human mast cell survival and homotypic adhesion

Por Moiseeva, Elena P., Leyland, Mark L., Bradding, Peter
Publicado em 2012

CADM1 is expressed as multiple alternatively spliced functional and dysfunctional isoforms in human mast cells

Por Moiseeva, Elena P., Leyland, Mark L., Bradding, Peter
Publicado em 2013

Adenosine closes the K(+) channel K(Ca)3.1 in human lung mast cells and inhibits their migration via the adenosine A(2A) receptor

Por Duffy, S Mark, Cruse, Glenn, Brightling, Christopher E, Bradding, Peter
Publicado em 2007

The Contribution of Orai(CRACM)1 and Orai(CRACM)2 Channels in Store-Operated Ca(2+) Entry and Mediator Release in Human Lung Mast Cells

Por Ashmole, Ian, Duffy, S. Mark, Leyland, Mark L., Bradding, Peter
Publicado em 2013

CADM1 Is a Key Receptor Mediating Human Mast Cell Adhesion to Human Lung Fibroblasts and Airway Smooth Muscle Cells

Por Moiseeva, Elena P., Roach, Katy M., Leyland, Mark L., Bradding, Peter
Publicado em 2013

CADM1 Controls Actin Cytoskeleton Assembly and Regulates Extracellular Matrix Adhesion in Human Mast Cells

Por Moiseeva, Elena P., Straatman, Kees R., Leyland, Mark L., Bradding, Peter
Publicado em 2014

Orai/CRACM1 and K(Ca)3.1 ion channels interact in the human lung mast cell plasma membrane

Por Duffy, S. Mark, Ashmole, Ian, Smallwood, Dawn T., Leyland, Mark L., Bradding, Peter
Publicado no Cell Commun Signal (2015)

Lipoxin A(4) Attenuates Constitutive and TGF-β1–Dependent Profibrotic Activity in Human Lung Myofibroblasts

Por Roach, Katy M., Feghali-Bostwick, Carol A., Amrani, Yassine, Bradding, Peter
Publicado no J Immunol (2015)

Bidirectional counter-regulation of human lung mast cell and airway smooth muscle β(2)-adrenoceptors

Por Lewis, Rebecca J., Chachi, Latifa, Newby, Chris, Amrani, Yassine, Bradding, Peter
Publicado no J Immunol (2015)

Engagement of the EP(2) prostanoid receptor closes the K(+) channel K(Ca)3.1 in human lung mast cells and attenuates their migration

Por Duffy, S Mark, Cruse, Glenn, Cockerill, Sarah L, Brightling, Chris E, Bradding, Peter
Publicado em 2008